DMC Share Price | Domesco Medical Import-Export JSC Stock Analysis & Recommendation

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Compare Domesco Medical Import-Export JSC with Similar Stocks

Binh Dinh Pharmaceutical & Medical Equipment JSC Imexpharm Corp.DHG Pharmaceutical JSC

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

High Management Efficiency with a high ROE of 11.92%

Company has very low debt and has enough cash to service the debt requirements

Poor long term growth as Net Sales has grown by an annual rate of 7.80% and Operating profit at -1.96% over the last 5 years

Negative results in Mar 25

With ROE of 9.32%, it has a fair valuation with a 1.33 Price to Book Value

Below par performance in long term as well as near term

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

VND 2,135,739 Million (Small Cap)

P/E

14.00

Industry P/E

Dividend Yield

4.07%

Debt Equity

-0.36

Return on Equity

9.77%

Price to Book

1.34

Revenue and Profits:

Net Sales:

559,004 Million

(Quarterly Results - Dec 2025)

Net Profit:

91,378 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-10.27%

6 Months

-5.05%

1 Year

-3.12%

2 Years

5.08%

3 Years

20.62%

4 Years

25.25%

5 Years

15.89%

Domesco Medical Import-Export JSC for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

7.80%

EBIT Growth (5y)

-1.96%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.23

Sales to Capital Employed (avg)

1.19

Tax Ratio

20.02%

Dividend Payout Ratio

50.39%

Pledged Shares

Institutional Holding

ROCE (avg)

19.73%

ROE (avg)

11.92%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.33

EV to EBIT

7.25

EV to EBITDA

6.67

EV to Capital Employed

1.52

EV to Sales

0.76

PEG Ratio

Dividend Yield

4.16%

ROCE (Latest)

20.95%

ROE (Latest)

9.32%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bollinger Bands

Bullish

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bullish

Bearish

Dow Theory

No Trend

Mildly Bullish

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is -2.02% vs 21.67% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 39.83% vs 33.00% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "559,004.00",
          "val2": "570,508.20",
          "chgp": "-2.02%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "105,409.90",
          "val2": "98,077.30",
          "chgp": "7.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "993.50",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "91,377.50",
          "val2": "65,347.10",
          "chgp": "39.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "188.60%",
          "val2": "164.10%",
          "chgp": "2.45%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 8.84% vs 10.49% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -2.31% vs 10.57% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,067,317.40",
          "val2": "1,899,426.90",
          "chgp": "8.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "239,970.30",
          "val2": "243,357.70",
          "chgp": "-1.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "93.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "168,327.00",
          "val2": "172,300.70",
          "chgp": "-2.31%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "106.70%",
          "val2": "119.00%",
          "chgp": "-1.23%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY

Dec'25

Dec'24

Change(%)

Net Sales

559,004.00

570,508.20

-2.02%

Operating Profit (PBDIT) excl Other Income

105,409.90

98,077.30

7.48%

Interest

993.50

0.00

Exceptional Items

0.00

Consolidate Net Profit

91,377.50

65,347.10

39.83%

Operating Profit Margin (Excl OI)

188.60%

164.10%

2.45%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Dec 2025 is -2.02% vs 21.67% in Dec 2024

Consolidated Net Profit

YoY Growth in quarter ended Dec 2025 is 39.83% vs 33.00% in Dec 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

2,067,317.40

1,899,426.90

8.84%

Operating Profit (PBDIT) excl Other Income

239,970.30

243,357.70

-1.39%

Interest

93.00

0.00

Exceptional Items

0.00

Consolidate Net Profit

168,327.00

172,300.70

-2.31%

Operating Profit Margin (Excl OI)

106.70%

119.00%

-1.23%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 8.84% vs 10.49% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -2.31% vs 10.57% in Dec 2024

All Annual Results

Company CV

About Domesco Medical Import-Export JSC

Domesco Medical Import-Export JSC

Pharmaceuticals & Biotechnology

Domesco Medical Import-Export Joint Stock Corporation (Domesco) is a Vietnam-based pharmaceutical company. Its principal activities include manufacturing, marketing and importing pharmaceutical products and materials for the manufacture of medicine for human, medical equipment, experimental chemicals, drinking water, mineral water and drinking water from medicine, wine, functional food and nutritious food. The Company is also active in the plantation of medical materials, as well as the manufacture, marketing, import and export of feed for poultry, cattle and aquatic animals, along with materials for the manufacture of animal feed. The Company has one subsidiary involved in the import, export and marketing of basic chemicals and other chemicals used in the production of industrial alcohol.

Company Coordinates

Company Details

So 66 - Quoc lo 30 - P. My Phu , CAO LANH None : None

Tel: 84 27 7385227884 067 3856326

http://www.domesco.com/

Registrar Details